Morgens Waterfall Vintiadis & CO Inc Amgen Inc Transaction History

Morgens Waterfall Vintiadis & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $1.36 Million - $1.62 Million	-6,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $1.25 Million - $1.53 Million	6,300 New	6,300 $1.49 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $421,975 - $471,475	-2,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $418,225 - $477,500	2,500	2,500 $466,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.